Dubai's stock market is peaking on the back of a surge in real estate activity and strong tourist flows.
Articles
In an unexpected twist, old coal plants are being repurposed to generate clean energy
Infrastructure from old coal power plants is being re-purposed to support clean energy projects.
Green groups demand US end talks on natural gas certification
The Biden administration's plan to create a standard for "certified" natural gas is facing stiff opposition from environmental groups.
Petrobras: A High-Yield Energy Stock That Is Undervalued
Brazil's national energy company currently looks cheap compared to some of its energy peers.
Climate protesters from This is Rigged blockade two oil sites in bid to 'shut down the Scottish oil industry'
Climate activists step up activities aimed at disrupting Scotland's oil industry.
Weak Global Economy, High Inflation, and Rising Fragmentation Demand Strong G20 Action
The IMF warns that the global economy requires strong action by the G20 to address multiple concerns.
atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update
Atai reports its Q2 2022 results, announces a new $175 million loan facility and streamlines its operations.
MindMed Board of Directors Approves Reverse Share Split
Mind Medicine announces a reverse share split of its common shares at a 1-15 ratio. Exchange symbols will remain the same but new CUSIP numbers will be assigned by the appropriate regulators.
COMPASS Pathways plc announces second quarter 2022 financial results and business highlights
Compass Pathways reports its Q2 2022 results. Preparing for its Phase 3 clinical trial for TRD. Net loss of $21.0 million. Cash (and equivalents) of $207.2 million.
COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa
Compass Pathways announces the launch of a Phase II clinical trial using psilocybin-based COMP360 as a treatment for anorexia nervosa.
Red Light Holland to Acquire Two Wellness Shops in the Netherlands: SmartShop Utrecht and SmartShop OSS
Red Light Holland acquires two of the Netherlands premier shops for psychedelic truffles and wellness products.
Pasithea Therapeutics Awarded a Drug Development Research Grant
Pasithea Therapeutics announces being awarded a research grant of AUD $1 million (US$694,000) for its psychedelics-based research for ALS disease.
Awakn Life Sciences' Phase III Trial Approved for Approximately CA$2.5 Million Funding from UK State Covering 66% of Costs
Awakn Life Sciences announces UK government grant funding to cover 2/3rds of the costs of its Phase III clinical trial for alcohol use disorder (AUD).
COMPASS Pathways appoints Kabir Nath as Chief Executive Officer
Compass Pathways announces that Kabir Nath will replace George Goldsmith as CEO effective August 1, 2022.
BetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research Team for BETR-001 Preclinical Depression Studies
Better Life Pharma announces additional funding to study BETR-001 as a treatment for depression, via the Mitacs Accelerate program.